Patent · US Active

Compounds for treatment of diseases related to DUX4 expression

US10973820B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

Facio Intellectual Property B.V. · NL

Inventors

Joris De Maeyer · Mechelen, BE
Marcus Geese · Oettingen, DE
Martin Schneider · Remchingen, DE
Sebastian Monecke · Göttingen, DE
Alexander Kaever · Göttingen, DE
Monika Ermann · Wantage, GB
Timothy Robin James · Woodstock, GB

Key dates

Filing date	Dec 12, 2018
Grant date	Apr 13, 2021
Priority date	—
Expiry date	Dec 12, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P21/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds for the treatment of diseases related to DUX4 expression, such as muscular dystrophies, wherein the disease is facioscapulohumeral muscular dystrophy (FSHD). It also relates to use of such compounds, or to methods of use of such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.